Qiagen NV | QIA - 売上総利益

株価
28.59
毎日の変更
0.24 0.85%
毎月
-19.71%
毎年
-23.99%
Q2 予測
27.51




売上総利益 変化する 日付
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
argenx SE USD 1.18B 40.98M 2026-03
Avita Medical AUD 14.31M 639K 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Ionis Pharmaceuticals USD 243M 48M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Moderna USD -566M 792M 2026-03
Organon & Co USD 854M 3M 2025-12
Qiagen NV USD 325.27M 19.53M 2025-12
Revvity USD 387.66M 34M 2026-03
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.38B 229.9M 2026-03
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12